Manuela Le Bars

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy

Mark C. Genovese, M. Schiff, Michael E. Luggen et al. · Annals of the Rheumatic Diseases · 2007 · 268 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study

Philip G. Conaghan, Maria Antonietta D’Agostino, Manuela Le Bars et al. · Annals of the Rheumatic Diseases · 2009 · 193 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial

Michael Schiff, C Pritchard, J. Eugene Huffstutter et al. · Annals of the Rheumatic Diseases · 2008 · 154 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study

Maria Antonietta D’Agostino, Richard J. Wakefield, Hilde Berner-Hammer et al. · Annals of the Rheumatic Diseases · 2016 · 102 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn’s Disease

Torsten Kucharzik, Rune Wilkens, Maria Antonietta D’Agostino et al. · Clinical Gastroenterology and Hepatology · 2022 · 97 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17